Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 14, 2021

SELL
$18.57 - $25.68 $182,691 - $252,639
-9,838 Closed
0 $0
Q4 2020

Jan 13, 2021

SELL
$15.26 - $28.61 $36,639 - $68,692
-2,401 Reduced 19.62%
9,838 $204,000
Q3 2020

Oct 15, 2020

SELL
$20.58 - $28.96 $6,297 - $8,861
-306 Reduced 2.44%
12,239 $265,000
Q2 2020

Jul 15, 2020

SELL
$11.15 - $24.64 $59,139 - $130,690
-5,304 Reduced 29.72%
12,545 $296,000
Q1 2020

Apr 17, 2020

BUY
$8.75 - $16.3 $30,913 - $57,587
3,533 Added 24.68%
17,849 $210,000
Q4 2019

Jan 15, 2020

SELL
$7.95 - $11.84 $11,813 - $17,594
-1,486 Reduced 9.4%
14,316 $152,000
Q3 2019

Oct 18, 2019

SELL
$10.82 - $14.25 $1,633 - $2,151
-151 Reduced 0.95%
15,802 $180,000
Q2 2019

Jul 11, 2019

SELL
$7.95 - $11.25 $2,846 - $4,027
-358 Reduced 2.19%
15,953 $179,000
Q1 2019

Apr 12, 2019

BUY
$5.95 - $10.19 $97,050 - $166,209
16,311 New
16,311 $132,000

Others Institutions Holding CYTK

About CYTOKINETICS INC


  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $4.03B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track First Citizens Bank & Trust CO Portfolio

Follow First Citizens Bank & Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Citizens Bank & Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on First Citizens Bank & Trust CO with notifications on news.